Foghorn Therapeutics (FHTX) has released an update to notify the public and investors about a regulation fd disclosure.
Foghorn Therapeutics Inc. is sharing a new investor presentation, dated February 2024, for upcoming discussions and meetings with investors. This information is provided for informational purposes and is not considered part of the company’s formal financial filings.
For further insights into FHTX stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
